🧪 Beta — BiohacksAI is under active development. Data and features may change.
B
BiohacksAI
Evidence-Based Biohacking
BetaPatent Pending

Nn Dimethyltryptamine

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Nn Dimethyltryptamine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

mk
3 shared targets
sb
3 shared targets
rs
3 shared targets
mesulergine
4 shared targets
lorcaserin
3 shared targets
sb
3 shared targets
glaucine
4 shared targets
bufotenine
2 shared targets
pimavanserin
2 shared targets
Psilocybin
3 shared targets · score 51.9
Loading evidence profile...

This evidence profile for Nn Dimethyltryptamine is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.